Qiagen NV
QIA: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€77.00 | Kml | Sdlyrjmv |
Qiagen Increases 2022 Outlook on Strong Q2 Trends; Shares Fairly Valued
Previous COVID-19 tailwinds started turning into headwinds for no-moat Qiagen in the second quarter but at a slower pace than previously anticipated. With the company's results tracking above our 2022 assumptions, we have increased our near-term expectations for Qiagen somewhat and mildly increased our fair value estimate, as well. However, we continue to view Qiagen shares as about fairly valued.